Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaomei Han

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Clinical Pharmacology and Therapeutics|August 29, 2018
Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA InitiativeZhihua Li, Bradley J Ridder, Xiaomei Han, et al.
JAMA|October 11, 2022
Effect of Paroxetine or Quetiapine Combined With Oxycodone vs Oxycodone Alone on Ventilation During Hypercapnia: A Randomized Clinical TrialJeffry Florian, Rutger van der Schrier, Victoria Gershuny, et al.
Journal of Pharmacological and Toxicological Methods|June 24, 2020
A general procedure to select calibration drugs for lab-specific validation and calibration of proarrhythmia risk prediction models: An illustrative example using the CiPA modelXiaomei Han, Mohammadreza Samieegohar, Bradley J Ridder, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Discovery and characterization of cross-reactive intrahepatic antibodies in severe alcoholic hepatitisAli Reza Ahmadi, Guang Song, Tianshun Gao, et al.
Elife|December 6, 2023
Discovery and characterization of cross-reactive intrahepatic antibodies in severe alcoholic hepatitisAli Reza Ahmadi, Guang Song, Tianshun Gao, et al.
Toxicology and Applied Pharmacology|March 27, 2020
A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigmBradley J Ridder, Derek J Leishman, Matthew Bridgland-Taylor, et al.
Clinical Pharmacology and Therapeutics|November 12, 2019
General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico StrategyZhihua Li, Gary R Mirams, Takashi Yoshinaga, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Clinical Pharmacology and Therapeutics|August 29, 2018
Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA InitiativeZhihua Li, Bradley J Ridder, Xiaomei Han, et al.
JAMA|October 11, 2022
Effect of Paroxetine or Quetiapine Combined With Oxycodone vs Oxycodone Alone on Ventilation During Hypercapnia: A Randomized Clinical TrialJeffry Florian, Rutger van der Schrier, Victoria Gershuny, et al.
Journal of Pharmacological and Toxicological Methods|June 24, 2020
A general procedure to select calibration drugs for lab-specific validation and calibration of proarrhythmia risk prediction models: An illustrative example using the CiPA modelXiaomei Han, Mohammadreza Samieegohar, Bradley J Ridder, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Discovery and characterization of cross-reactive intrahepatic antibodies in severe alcoholic hepatitisAli Reza Ahmadi, Guang Song, Tianshun Gao, et al.
Elife|December 6, 2023
Discovery and characterization of cross-reactive intrahepatic antibodies in severe alcoholic hepatitisAli Reza Ahmadi, Guang Song, Tianshun Gao, et al.
Toxicology and Applied Pharmacology|March 27, 2020
A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigmBradley J Ridder, Derek J Leishman, Matthew Bridgland-Taylor, et al.
Clinical Pharmacology and Therapeutics|November 12, 2019
General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico StrategyZhihua Li, Gary R Mirams, Takashi Yoshinaga, et al.
Pageof 4